SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 807.00
+19.00 (2.41%)
At close: Apr 3, 2026
SCM Lifescience Market Cap
SCM Lifescience has a market cap or net worth of 35.67 billion as of April 2, 2026. Its market cap has increased by 42.63% in one year.
Market Cap
35.67B
Enterprise Value
26.77B
Revenue
1.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
807.00
Market Cap Chart
Since June 17, 2020, SCM Lifescience's market cap has decreased from 398.06B to 35.67B, a decrease of -91.04%. That is a compound annual growth rate of -34.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 35.67B | -20.26% |
| Dec 30, 2025 | 44.73B | 15.58% |
| Dec 30, 2024 | 38.70B | -49.97% |
| Dec 28, 2023 | 77.37B | -55.83% |
| Dec 29, 2022 | 175.14B | -25.10% |
| Dec 30, 2021 | 233.83B | -60.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 61.70B |
| ADBiotech | 61.01B |
| IMGT Co.,Ltd. | 59.29B |
| Parataxis Korea | 49.64B |
| J2KBIO | 43.97B |
| NGeneBio | 43.38B |
| MOA Life Plus | 42.89B |
| Kainos Medicine | 35.56B |